Results 111 to 120 of about 228,208 (202)

Current Research in Polypharmacology for Cancer Treatment Using Dual-Target Histone Deacetylase Inhibitors. [PDF]

Int J Mol Sci
Yudaev P, Aleksandrova Y, Neganova M.
europepmc   +1 more source

Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitor. [PDF]

Nat Commun
Rodrigues DA, Wang Y, Goulart Stollmaier J, Sullivan GP, D'Arcy C, Coughlan AY, Roe A, Bíró L, Watson PR, Osko JD, Twamley B, Wynne K, Cagney G, Buglyó P, Liu Y, Griffith DM, Christianson DW, Chonghaile TN.   +17 more
europepmc   +1 more source

Tuft cells protect against intestinal inflammation through histone deacetylase 3. [PDF]

Mucosal Immunol
Eshleman EM, Rice T, Waddell A, Kumar S, Didriksen BJ, Engleman L, Vidyant S, Sayed M, Karns R, Lim HW, Denson LA, Alenghat T.   +11 more
europepmc   +1 more source

Histone deacetylase 3‑mediated histone deacetylation combined with activating transcription factor 3 promotes renal fibrosis by inhibiting Klotho. [PDF]

Mol Med Rep
Yang Z, Wang X, Li W, Chen H, Liu G.
europepmc   +1 more source

Transient histone deacetylase inhibition reveals cell type invariant and specific effects of chromatin decondensation on irradiation response. [PDF]

Front Cell Dev Biol
Li H, Maben C, Young L, Pal D, Davern S, McCord RP.   +5 more
europepmc   +1 more source

Correction: Histone deacetylase inhibitors are protective in acute but not in chronic models of ototoxicity. [PDF]

Front Cell Neurosci
Yang CH, Liu Z, Dong D, Schacht J, Arya D, Sha SH.   +5 more
europepmc   +1 more source

Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy. [PDF]

Int J Pharm
Oyebade A, Hossain MR, Hasan M, Oluremi A, Rahman MS, Ali N, Griffin RJ, Oyelere AK, Siraj N.   +8 more
europepmc   +1 more source

In vitro characterization of the catalytic domain of human histone deacetylase 5. [PDF]

Sci Rep
Mammen C, Hornung FM, Anzenhofer C, Schumacher J, Reiners J, Li J, Mazzone F, Bilsing FL, Kassack MU, Kurz T, Smits SHJ.   +10 more
europepmc   +1 more source

Histone Deacetylase-2 Expression in Colorectal Cancer: An Immunohistochemical Study and Its Clinicopathological Significance. [PDF]

Cancers (Basel)
Garmpis N, Nonni A, Dimitroulis D, Effraimidou EI, Garmpi A, Papandroudis MP, Kontzoglou K, Damaskos C.   +7 more
europepmc   +1 more source

Design, Synthesis, In Vitro Evaluation, and Molecular Docking of 4-Substituted Anilides as Histone Deacetylase Inhibitors and Potential Anticancer Agents. [PDF]

Chem Biodivers
Lisouskaya M, Panibrat A, Kayumov M, Yuldashev K, Syakhovich V, Mikhal'chuk A.   +5 more
europepmc   +1 more source